The new WHO-classification 2022

What remains? What is new?

The WHO book Haematolymphoid Tumours is now available as a Beta version:

MLL Munich Leukemia Laboratory

Leukemia diagnostics for targeted therapy of your patients

What we offer

Diagnostics

We are interdisciplinary experts. Our goal is to provide the best leukemia diagnostics for our patients by offering a comprehensive set of methods, state-of-the-art technology and continuous development.

Read more

Big Data

We empower physicians, biologists, scientists, and researchers with web-based tools that assist in variant interpretation of sequencing data in hematologic neoplasms.

Read more

Pharma

We have a wealth of experience supporting clinical research from clinical trial design to post-launch diagnostics.

Read more

Research

Through a large number of in-house scientific projects as well as national and international collaborations, we contribute to the improvement of leukemia and lymphoma diagnostics and risk stratification of patients.

Read more

Methods


Focused methods for leukemia diagnostics form the basis for a specific therapy.

Corporate film 2020

About us

982286

Samples received since 2005

673

Publications

262

Employees

913

Devices


News

Our MLLSEQ next generation sequencing service
We have launched the new label MLLSEQ
and outfitted it with its own logo
and a completely new Website.

MLL magazine

You may also be interested in

Career

As a rapidly growing, innovative medical laboratory, we are always looking for bright minds to help us bring new and more effective therapies to patients around the world.

Learn more

Services

Do you have questions about sample submission, analyses performed or findings? Here you will find contact details, contact persons and our most frequently asked questions (FAQs).

Learn more

Quality management

We have been certified according to national and international standards since 2009 and have successfully maintained these accreditations.

Learn more

Your contact person

»Patient wellbeing and digitalization are not a contradiction, but the future.«

Prof. Dr. med. Dr. phil. Torsten Haferlach

Executive management
Internist, Hematologist and Oncologist
Deputy Head of Cytomorphology

T: +49 89 99017-100